|
| |
ICSSince 1996, specialty pharmaceutical and biotechnology companies have relied on Intergrated Commercialization Solutions (ICS) to bring their products to market. We are the experts when it comes to marketing, managing and distributing temperature-sensitive products, controlled substances and products requiring FDA mandated restricted access. ICS offers the specialized services that specialty pharmaceutical and biotechnology companies need to bring their products to market. From outsourced logistics and medical science liaison services to medical information and contract management, ICS’ services make us your essential partner for product launch and market expansion initiatives
| Contact Details: |
| 4006 Belt Line Rd. |
| Addison |
| Texas |
| 75001 |
| United States of America |
| Tel: | 888.285.7481 |
| Fax: | |
| Email: | marketing@icsconnect.com |
| WWW: | www.icsconnect.com/

|
|
Loading...
|
Recent Publications by ICS: |  |
Geometric evolutionary dynamics of protein interaction networks.
Understanding the evolution and structure of protein-protein interaction... | 13th November, 2009
| Department of Computer Science, University of California, Irvine, CA,
| Pac Symp Biocomput. 2010:178-89.
|
[Lymphogranuloma venereum: an emerging cause of proctitis in homosexual men in Barcelona]
BACKGROUND AND OBJECTIVE: Lymphogranuloma venereum (LGV) is a systemic... | 29th October, 2009
| Unidad de Infecciones de Transmision Sexual, Centro de Atencion Primaria
| Rev Clin Esp. 2009 Feb;209(2):78-81.
|
[A new sense for living: a comprehensive study about the adaptation process following spinal cord injuries]
The present study exploresanddescribesthe adaptation phenomena following... | 22nd October, 2009
| Instituto de Ciencias da Saude da Universidade Catolica Portuguesa, Porto,
| Rev Esc Enferm USP. 2009 Sep;43(3):573-80.
|
Cognitive versus behavioral ADHD phenotype: what is it all about?
The ADHD PASS assessment is discussed. 100 combined and 50 inattentive... | 17th October, 2009
| Hospital Universitari Dr J Trueta, Department of Neuropediatrics, Girona,
| Neuropediatrics. 2009 Feb;40(1):32-8. Epub 2009 Jul 28.
DOI Direct Link |
[Development of primary health care competencies]
Given that the lack of qualified human resources devoted to primary health... | 10th October, 2009
| Organizacion Panamericana de la Salud, Asesora Regional de Servicios de
| Rev Panam Salud Publica. 2009 Aug;26(2):176-83.
|
→View more ICS research publications. |
Press Releases on ICS:
|
 |
| Aerovance Completes Patient Enrollment in Phase 2b Clinical Trial of Aerovant(TM) for Treatment of Uncontrolled Asthma |
3rd November, 2009 |
Aerovance Inc. |
BERKELEY, Calif., Nov. 3 /PRNewswire/ -- Aerovance Inc. today announced it has completed patient enrollment in a Phase 2b clinical trial of the inhaled dry powder formulation of Aerovant for the
|
| Urgent(R) PC and Macroplastique(R) Featured in Numerous International Continence Society Meeting Sessions |
6th October, 2009 |
Uroplasty, Inc. |
-- "Is Cost the Achilles Heel of Posterior Tibial Nerve Stimulation? A Cost
Minimisation Comparison with Antimuscarinic Therapy in the Management of
OAB," a poster
|
| REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder |
7th September, 2009 |
|
LONDON, September 7 /PRNewswire/ -- Regurin(R) XL (trospium chloride), a once-daily,
prolonged-release capsule to treat patients with overactive bladder (OAB) has
been launched in the UK. Regurin(R)
|
| Latest Guidance Issued by BTS/SIGN Supports use of Single Inhaler for Maintenance and Relief in Asthmatic Patients |
2nd July, 2009 |
|
LONDON, July 2 /PRNewswire/ -- Updated guidelines issued this week by the British Thoracic Society (BTS)
and Scottish Intercollegiate Guidelines Network (SIGN) include the use of
budesonide/formoterol
|
| An Increase in the Diagnosed Prevalent Population Will Drive Growth of Nearly $4.3 Billion in the Chronic Obstructive Pulmonary Disease Market |
23rd June, 2009 |
Decision Resources |
Emerging Combination Products from GlaxoSmithKline/Theravance, Boehringer Ingelheim and Novartis Will Drive Growth, According to a New Report from Decision Resources
WALTHAM, Mass., June 23
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 76 individuals from ICS using this service. Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 283 times since April 2007, the link to the organisation's website has been followed 56 times Search for more companies in Addison Search for more companies in Texas This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for ICS |